Dr. House vs UrWay Health: Compare GLP-1 Programs & Pricing
Side-by-side Dr. House and UrWay Health: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
Dr. House and UrWay Health are two established telehealth providers offering GLP-1–based weight management programs. This article compares Dr. House vs UrWay Health to help you identify which best fits your goals and preferences. It focuses on program flow, pricing transparency, clinical oversight, medication quality, and customer experience while noting telehealth and FDA-related considerations.
Visit Dr. House
Explore UrWay Health
Dr. House vs UrWay Health: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| Dr. House | Not disclosed | Not disclosed | (Code: ) | — No |
| UrWay Health | Not disclosed | Not disclosed | (Code: ) | — No |
Dr. House vs UrWay Health: Medical Process & Accessibility
Dr. House typically emphasizes rapid telehealth intake and efficient clinician review to approve appropriate prescriptions when clinically indicated. UrWay Health positions itself around structured follow-ups and dose optimization driven by regular check-ins. Both require a medical evaluation by a licensed clinician before any GLP-1 is prescribed, and both operate within U.S. telehealth regulations.
Dr. House vs UrWay Health: Pricing Comparison
Neither provider publicly lists a single universal starting price on every plan; pricing can vary by dose, formulation, local pharmacy fulfillment, and whether compounded or branded formulations are prescribed. For clarity in this comparison we show each provider’s semaglutide and tirzepatide entries as Not disclosed when a fixed public starting price is not available. Always confirm the full cost during your intake visit.
Common cost factors include initial consultation fees, prescription cost (pharmacy charges), shipping, and any optional follow-up or coaching packages. Because membership is not required with either provider (both list “No” for membership in public materials), upfront costs tend to focus on per-prescription and consultation charges rather than ongoing mandatory fees.
Dr. House vs UrWay Health: Clinical Oversight & Support
Both services connect patients with licensed clinicians who evaluate medical history, potential contraindications, and appropriate dosing. Telehealth clinicians will screen for heart disease, history of pancreatitis, pregnancy or planning pregnancy, and other conditions where GLP-1s may be inappropriate. They will not prescribe without clinical justification and appropriate monitoring plans.
Book a Consultation with Dr. House
Dr. House vs UrWay Health: Medication Quality & Safety
When telehealth providers prescribe GLP-1 therapies, prescriptions may be filled as branded FDA-approved products (e.g., Wegovy® for semaglutide) where available or as compounded formulations from accredited U.S. compounding pharmacies. Compounded alternatives are legal when prescribed by a clinician but are not individually FDA-approved products — they are preparations made by a pharmacy per prescription. This difference is important: branded drugs have undergone FDA evaluation, while compounded products have not been evaluated in the same way.
Learn More about Medication Options
Dr. House vs UrWay Health: Customer Experience
Feedback commonly highlights Dr. House for streamlined onboarding and affordability, whereas UrWay Health receives praise for clinician touchpoints and tailored dose adjustments. Shipping times and pharmacy reliability are major determinants of satisfaction; both companies typically work with U.S. pharmacies that ship within several days after approval, but actual delivery times and customer service responsiveness vary.
Dr. House vs UrWay Health: Final Verdict
Choose Dr. House if you prioritize fast onboarding and an emphasis on cost-conscious options. Choose UrWay Health if you prefer structured follow-ups and more clinician-driven dose optimization. Both are legitimate telehealth pathways to access GLP-1 therapies under medical supervision; however, individual outcomes and experiences differ, so review terms, pharmacy partners, and clinical protocols before enrolling.
Join Dr. House
Get Started with UrWay Health
Disclaimer
This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. GLP-1 medications should only be used under the supervision of a licensed clinician. Branded GLP-1 formulations are FDA-approved for specific indications; compounded alternatives are dispensed under prescription but are not themselves FDA-approved products. Always consult a licensed clinician before beginning or changing any medical treatment.